Fauci says Pfizer coronavirus vaccine likely available for high-risk cases by December

Fauci says Pfizer coronavirus vaccine likely available for high-risk cases by December

Dr. Anthony Fauci, the U.S. government's top infectious disease expert, said that a coronavirus vaccine could be available for the nation's highest-risk individuals as soon as December.

Dr. Anthony Fauci, the U.S. government's top infectious disease expert, said that a coronavirus vaccine could be available for the nation's highest-risk individuals as soon as December.

COVID-19 vaccine timeline: A look at what’s ahead for leading candidates

COVID-19 vaccine timeline: A look at what’s ahead for leading candidates

Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.

Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.

AstraZeneca plans to deliver vaccine trial data by year's end

AstraZeneca plans to deliver vaccine trial data by year's end

AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.

AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.

Fauci estimates COVID-19 vaccine won’t be available until January 2021 or later

Fauci estimates COVID-19 vaccine won’t be available until January 2021 or later

The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.

The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.

Behind-the-scenes of the COVID-19 vaccine approval process
video

Behind-the-scenes of the COVID-19 vaccine approval process

Dr. Gregory Huhn, infectious disease physician at Cook County Health, talks about the rollout of potential coronavirus vaccines and how it could play out in 2021.

Dr. Gregory Huhn, infectious disease physician at Cook County Health, talks about the rollout of potential coronavirus vaccines and how it could play out in 2021.

FDA allows AstraZeneca’s COVID-19 vaccine trial to resume in US

FDA allows AstraZeneca’s COVID-19 vaccine trial to resume in US

The late-stage trial of a leading COVID-19 vaccine candidate from AstraZeneca and the University of Oxford will resume in the U.S., according to a report from the Wall Street Journal.

The late-stage trial of a leading COVID-19 vaccine candidate from AstraZeneca and the University of Oxford will resume in the U.S., according to a report from the Wall Street Journal.

Pfizer to start testing COVID-19 vaccine in kids

Pfizer to start testing COVID-19 vaccine in kids

Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.

Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.